Citation, DOI, disclosures and article data
At the time the article was created Matt A. Morgan had no recorded disclosures.View Matt A. Morgan's current disclosures
At the time the article was last revised Jeremy Jones had no recorded disclosures.View Jeremy Jones's current disclosures
Hepatic leiomyosarcomas are rare primary malignant tumors derived from smooth muscle cells in the liver.
Hepatic leiomyosarcoma is rare 1. An equal sex distribution and a broad age range (5 months-66Y) has been reported. Some have suggested an associated with AIDS 2.
The tumor may derive from smooth muscle cells of the bile ducts or blood vessels. No underlying etiologic factors are known. Not associated with cirrhosis, but may be related to EBV. C-kit negative (differentiates it from GIST).
Uniform spindle cells with blunt nuclear ends. Variable mitoses. A few large cells may be noted.
Vimentin and desmin positive.
- "pseudocystic pattern" with heterogeneous enhancement 3
- commonly large at diagnosis (6-35 cm)
- may be predisposed to rupture/hemorrhage 4
- pedunculated leiomyosarcoma has been reported and may arise from the ligamentum teres
- relatively well-marginated mass
- heterogeneous T2 signal
- intratumoral hemorrhage may result in patchy increase in T1 signal
- slowly increasing enhancement on later postcontrast dynamic phases
- foci of restricted diffusion
- markedly hypermetabolic
- hepatocellular carcinoma
- fibrolamellar hepatocellular carcinoma
- metastatic nonhepatic leiomyosarcoma (e.g. uterus, gastrointestinal, etc)
- malignant fibrous histiocytoma
- spindle cell hepatocellular carcinoma
- solitary fibrous mesothelioma
Treatment and prognosis
Surgical resection is the standard treatment but with the rarity of the tumor, its effectiveness is uncertain. It had previously been reported that the majority of patients have recurrent tumor and some develop widespread metastatic disease, however, some recent studies suggest that this prognosis was based on some earlier misclassification of GIST tumors as hepatic leiomyosarcomas 5,7. The clinical course of a pedunculated leiomyosarcoma may be benign 6.
- 1. Chen KT. Hepatic leiomyosarcoma. J Surg Oncol. 1984;24 (4): 325-8. Pubmed citation
- 2. Metta H, Corti M, Trione N et-al. Primary Hepatic Leiomyosarcoma-a Rare Neoplasm in an Adult Patient with AIDS: Second Case Report and Literature Review. J Gastrointest Cancer. . doi:10.1007/s12029-013-9525-3 - Pubmed citation
- 3. Soyer P, Bluemke DA, Riopel M et-al. Hepatic leiomyosarcomas: CT features with pathologic correlation. Eur J Radiol. 1995;19 (3): 177-82. Pubmed citation
- 4. Majumder S, Dedania B, Rezaizadeh H et-al. Tumor rupture as the initial manifestation of primary hepatic leiomyosarcoma. Gastrointest Cancer Res. 2014;7 (1): 33-4. Free text at pubmed - Pubmed citation
- 5. Fong JA, Ruebner BH. Primary leiomyosarcoma of the liver. Hum. Pathol. 1974;5 (1): 115-9. Pubmed citation
- 6. Tomaszewski MM, Kuenster JT, Hartman K. Leiomyosarcoma of ligamentum teres of liver: case report. Pediatr Pathol. 1986;5 (2): 147-56. Pubmed citation
- 7. Hamed MO, Roberts KJ, Merchant W et-al. Contemporary management and classification of hepatic leiomyosarcoma. HPB (Oxford). 2014; . doi:10.1111/hpb.12366 - Pubmed citation